MARKET INTELLIGENCE REPORT

Global Baby Milk Powder Market

Infant Nutrition Industry — Comprehensive Analysis, Competitive Landscape & Forecast 2025–2036

Historical Coverage: 2020–2024  |  Base Year: 2025  |  Forecast Period: 2025–2036

Executive Summary

The global Baby Milk Powder market represents one of the most essential and resilient segments within the broader infant nutrition and fast-moving consumer goods industries. Baby milk powder — encompassing infant formula, follow-on formula, toddler milk, and specialized medical nutrition products — serves as the primary or supplementary nutrition source for infants and young children globally when breastfeeding is not possible, insufficient, or discontinued. Its role in ensuring adequate early-life nutrition makes it not merely a consumer product but a public health imperative, underpinning its structural demand stability through varied economic cycles.

This report presents a comprehensive original analysis of the global Baby Milk Powder market across three product type categories — General Baby Milk Powder, Special Formula Baby Milk Powder, and Premature Infant Baby Milk Powder — alongside four age-based end-use segments spanning infants under 6 months through children above 3 years of age. Geographic coverage encompasses the United States, Europe, China, Japan, Southeast Asia, and India, with historical data from 2020 to 2024 and projections through the 2036 forecast horizon.

Key findings from this research include:

•       The global Baby Milk Powder market is on a sustained growth trajectory, supported by rising birth rates in developing economies, increasing urbanization driving shifts away from exclusive breastfeeding, growing maternal workforce participation, and an intensifying parental focus on scientifically formulated early-life nutrition.

•       General Baby Milk Powder remains the largest product segment by volume, while Special Formula and Premature Infant categories are growing at above-average rates as neonatal care improves and allergy and metabolic condition prevalence among infants is more widely diagnosed and addressed.

•       The Infant Under 6 Months segment commands the highest premium pricing and most intensive innovation activity, as this developmental window represents the most nutritionally critical and clinically sensitive feeding period.

•       China dominates global market value, combining the world's largest cohort of urban affluent infant nutrition consumers with a powerful premiumization dynamic that drives average formula prices well above global norms. India and Southeast Asia represent the fastest-growing regional opportunities by volume.

•       The competitive landscape is dominated by a small group of globally trusted brands — Nestle, Abbott, Mead Johnson (now part of Reckitt), Wyeth (Nestle), and Danone's Dumex — alongside fast-growing Chinese domestic champions including YILI and Ausnutria, creating a market that balances global brand trust with local relevance.

Market Overview

Market Definition & Scope

Baby Milk Powder, broadly defined as any dried milk-based or plant-based powder product formulated to meet the nutritional needs of infants and young children from birth through early childhood, encompasses a wide range of product formulations spanning standard cow's milk-based infant formula, extensively hydrolyzed hypoallergenic formulas, amino acid-based elemental formulas for severe allergy management, lactose-free formulations for lactose intolerance, organic and premium-positioned standard formulas, and specialized medical nutrition products for premature infants requiring fortified caloric and nutrient density.

The market operates across four nutritional stages that correspond to the developmental phases of early childhood. Stage 1 (birth to 6 months) covers infant formula intended as a complete sole-source nutrition alternative or supplement to breastfeeding. Stage 2 (6 to 12 months) encompasses follow-on formulas designed to complement the introduction of solid foods while continuing to provide key nutrients including iron, calcium, and essential fatty acids. Stage 3 (12 to 36 months) covers growing-up milks or toddler formulas that support nutritional completeness during the transition to family foods. Stage 4 (above 3 years) includes junior milks and fortified powders designed to supplement the diets of preschool and early school-age children with targeted micronutrients.

This report encompasses all four age-stage product categories alongside the three primary product type classifications: General Baby Milk Powder (standard formulations), Special Formula Baby Milk Powder (medical and condition-specific formulas), and Premature Infant Baby Milk Powder (specialized neonatal nutrition products). Geographic scope covers six primary regional markets with extended sub-regional analysis available across North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

Industry Context: Infant Nutrition & Public Health

The Baby Milk Powder market operates at the intersection of consumer goods and healthcare, subject to stringent regulatory oversight in virtually every major market globally. National and international regulatory frameworks — including Codex Alimentarius standards, EU Directive 2006/52/EC and its successors, FDA regulations in the United States, and country-specific regulations across Asia — govern the composition, labeling, marketing, and distribution of infant formula products, creating significant compliance requirements that simultaneously protect consumers and create barriers to market entry.

The WHO International Code of Marketing of Breast-Milk Substitutes and subsequent World Health Assembly resolutions establish global guidance on the appropriate marketing of formula products, restricting promotional activities directed at parents and healthcare providers in many jurisdictions. Manufacturers operating in this market must navigate this complex regulatory and ethical landscape alongside intense competitive dynamics — a combination that fundamentally shapes product strategy, brand investment, and distribution approaches across the industry.

The market is also deeply influenced by demographic trends — global birth rates, urbanization patterns, maternal employment rates, and the evolution of breastfeeding culture across different societies — that collectively determine the total available population of infant formula users and the intensity of formula consumption within that population.

Historical Market Performance (2020–2024)

The 2020–2024 review period was marked by a series of consequential developments that shaped the global Baby Milk Powder market's trajectory in both challenging and constructive ways. The COVID-19 pandemic introduced supply chain disruptions, logistics complexity, and retail channel shifts that affected availability and distribution patterns globally in 2020 and 2021. In the United States, the market experienced a significant structural shock in 2022 when a major manufacturing plant shutdown triggered a severe nationwide infant formula shortage — an event that exposed the fragility of concentrated manufacturing infrastructure and prompted both regulatory response and sustained investment in domestic production capacity.

Simultaneously, the pandemic accelerated e-commerce adoption in the baby nutrition category across all major markets, with online platforms — including major e-commerce marketplaces, pharmacy-affiliated digital stores, and direct-to-consumer brand channels — growing their share of total formula sales substantially. This channel shift has persisted and strengthened through 2023–2024, fundamentally reshaping the distribution economics and direct consumer relationship dynamics of the market.

China's market underwent a significant regulatory transformation during this period, with the implementation of National Food Safety Standards requiring all formula products sold in China to obtain formula registration certificates — a process that eliminated thousands of unregistered or non-compliant products and dramatically consolidated the competitive landscape in favor of domestically registered brands with compliant formulations. This regulatory environment has both raised quality standards and concentrated market share, benefiting established domestic players including YILI, Ausnutria, and Scient alongside international brands that successfully navigated the registration process.

By 2023–2024, the global market had normalized onto a growth path characterized by premiumization in mature markets, volume expansion in developing economies, continued product innovation in functional and specialized formulas, and growing competition between international and domestic brands in Asian markets.

Market Segmentation Analysis

By Product Type

General Baby Milk Powder

General Baby Milk Powder — comprising standard cow's milk-based infant formula, follow-on formula, and growing-up milk across all age stages — constitutes the largest segment by both volume and absolute revenue in the global market. These products are formulated to meet the complete nutritional requirements of healthy infants and young children without specific dietary restrictions or medical conditions, using casein and whey protein fractions, lactose, plant-derived lipids including essential fatty acids, and a comprehensive micronutrient profile designed to approximate the nutritional composition of human breast milk.

Premium positioning within the General Baby Milk Powder segment has become an increasingly powerful commercial dynamic, particularly in China and other Asian markets where parental willingness to invest in premium-priced formulas with enhanced ingredient profiles — including added DHA, ARA, HMO (Human Milk Oligosaccharides), probiotics, prebiotics, and organic certifications — is driving significant average selling price elevation. The premiumization of standard formula has been one of the most important value-growth drivers in the market over the past decade and is expected to continue through the forecast period.

Special Formula Baby Milk Powder

Special Formula Baby Milk Powder encompasses the full range of medically indicated and condition-specific infant nutrition products designed for infants with specific dietary, metabolic, or immunological needs that prevent them from tolerating standard formula. This category includes extensively hydrolyzed formulas for cow's milk protein allergy (CMPA) — the most common food allergy in infancy — amino acid-based elemental formulas for severe allergy or gastrointestinal disorders, anti-reflux formulas with thickening agents, lactose-free formulas for lactose intolerance or galactosemia, soy-based formulas, metabolic disorder formulas for conditions including PKU and maple syrup urine disease, and a growing range of functional formulas incorporating probiotic strains, postbiotics, and gut microbiome-supporting ingredients.

The Special Formula segment is recording the strongest growth rate within the product type landscape, driven by several converging trends: increasing clinical diagnosis rates of infant food allergies and intolerances, growing awareness among pediatricians and parents of functional formula benefits, the expansion of neonatal and pediatric healthcare capabilities in emerging markets, and significant investment by leading manufacturers in proprietary special formula platforms that command substantial price premiums and strong brand loyalty.

Premature Infant Baby Milk Powder

Premature Infant Baby Milk Powder represents the most clinically specialized and highest-value niche within the Baby Milk Powder market. Products in this category are specifically engineered for infants born before 37 weeks gestation, who require substantially higher caloric density, elevated protein content, enhanced mineral supplementation (particularly calcium and phosphorus for bone mineralization), and targeted micronutrient profiles to support the accelerated catch-up growth required outside the womb.

This segment is closely tied to neonatal intensive care infrastructure and is primarily distributed through hospital pharmacies, neonatal departments, and specialized pediatric nutrition channels rather than retail. The global increase in premature birth rates — associated with factors including maternal age at first birth, assisted reproductive technology use, and multiple gestations — is expanding the clinical patient population for these products. Simultaneously, improvements in neonatal survival rates in middle-income countries are expanding the geographic addressable market for premature infant formula as healthcare infrastructure develops.

By Age-Stage Application

Infant Under 6 Months (Stage 1)

The Under 6 Months segment represents the most commercially valuable and clinically critical feeding period in the Baby Milk Powder market. Stage 1 infant formula is designed for use from birth as the sole nutritional source when breastfeeding is not practiced or is supplemented, and must meet the most stringent nutritional completeness standards of any age stage. This segment commands the highest average selling prices across the product age range, reflects the greatest intensity of parental anxiety and investment in premium nutrition, and is the primary focus of manufacturer research and development investment.

Innovation in the Under 6 Months segment is centered on increasingly close approximation of human breast milk composition, particularly regarding bioactive components. The commercial introduction of Human Milk Oligosaccharides (HMOs) — complex prebiotic sugars present in breast milk that support infant gut microbiome development and immune function — has been the most significant Stage 1 product innovation of the past decade, with leading brands incorporating multiple HMO structures and marketing this advancement as a step-change improvement in formula quality.

Infant Between 6 and 12 Months (Stage 2)

Stage 2 follow-on formula is designed to complement the introduction of solid foods from 6 months onward, providing continued nutritional insurance as dietary variety begins to expand. Key nutritional priorities in this stage include iron provision — supporting cognitive development and preventing the iron deficiency anemia to which infants become vulnerable as maternal iron stores are depleted — and continued essential fatty acid delivery for ongoing brain and visual development.

This segment is commercially significant as it extends the formula feeding relationship and revenue stream through the important first year of life. Many parents who began feeding Stage 1 formula continue into Stage 2 under the same brand, making retention from Stage 1 an important commercial dynamic — one that leading brands actively manage through stage-consistent packaging, taste profile continuity, and communication that reinforces brand trust across the transition.

Infant Between 12 and 36 Months (Stage 3)

Stage 3 growing-up milks and toddler formulas serve children in the 12–36 month developmental window, a period characterized by rapid expansion of dietary variety but continued potential for nutritional gaps — particularly regarding iron, vitamin D, omega-3 fatty acids, and other micronutrients that can be difficult to provide adequately through unsupplemented family foods in this age group. Growing-up milks are positioned as nutritional insurance products that bridge the gap between infant formula and unfortified standard dairy milk or plant-based alternatives.

This segment has grown substantially as manufacturers and pediatric nutritionists have drawn attention to the prevalence of micronutrient deficiencies in toddlers eating conventional diets. The market has also benefited from parental extension of formula purchasing habits beyond the first year of life, driven by both genuine nutritional benefit and effective brand communications that maintain parent engagement through the transition to solid and family foods.

Infant Above 3 Years (Stage 4+)

The Stage 4 and above segment encompasses junior milks, preschool nutrition powders, and fortified growing-up drinks targeting children from 3 years through early school age. While the nutritional rationale for formula use diminishes as dietary variety and complexity expand in this age group, the commercial opportunity has been actively developed by manufacturers in Asian markets — particularly China, Southeast Asia, and India — where parental concern about dietary completeness and cognitive development fuels consistent demand for fortified nutritional products well beyond the traditional formula-feeding window.

Regional Market Analysis

United States

The United States is one of the world's largest Baby Milk Powder markets by value, characterized by high average formula prices, strong brand loyalty, and a sophisticated regulatory environment administered by the FDA. The 2022 infant formula shortage — triggered by the contamination-related shutdown of a major domestic manufacturing facility — exposed structural vulnerabilities in the US supply chain and catalyzed significant policy attention toward domestic manufacturing capacity and supply chain resilience. The government's emergency import program, which temporarily allowed international formula brands to enter the market under expedited review, introduced American parents to European formula brands and sparked lasting interest in imported premium products.

In the post-shortage environment, the US market has seen increased competition, greater consumer awareness of formula options beyond the legacy domestic brands, and sustained investment by both domestic manufacturers and international players seeking to establish or expand US market presence. Specialty and hypoallergenic formulas are growing rapidly in the US, driven by increasing rates of allergy and sensitivity diagnosis and a pediatric healthcare community that is increasingly vocal about the nutritional benefits of condition-specific formula. The e-commerce and direct-to-consumer channel has grown significantly as a formula purchasing platform.

Europe

Europe represents a mature, highly regulated, and quality-focused Baby Milk Powder market. The European regulatory framework for infant formula — among the most stringent globally — establishes detailed compositional requirements, prohibits certain marketing practices, and has recently undergone significant modernization to address new ingredient categories including HMOs, probiotics, and DHA sourcing standards. This regulatory rigor creates a high barrier to product innovation introduction but simultaneously assures consumers of product safety and quality standards that are among the world's highest.

Western European markets including Germany, France, the UK, and the Netherlands are characterized by high breastfeeding initiation rates — which moderate formula market penetration — but also by strong parental investment in premium-quality formulas when breastfeeding is supplemented or discontinued. Organic formula has achieved particularly strong market penetration in Germany and other Northern European markets where organic food purchasing is culturally embedded as a standard parental choice. European formula brands including HiPP and Aptamil (Danone) command premium positions domestically and have developed significant cross-border demand from Chinese parents seeking European-origin premium formula.

China

China is the world's single most valuable national Baby Milk Powder market and the dominant driver of global premium formula revenue. The country's combination of a large and deeply invested urban parent population, high disposable incomes among the post-80s and post-90s parental generation, historical quality concerns regarding domestically produced formula (stemming from the 2008 melamine contamination crisis), and a cultural emphasis on optimal early-childhood nutrition investment has created a market environment where premium and ultra-premium formula pricing is accepted and actively sought by a large consumer segment.

China's regulatory transformation — through the Formula Registration System implemented progressively from 2018 — has fundamentally restructured the market by eliminating thousands of non-compliant or unregistered brands and concentrating sales among registered domestic and international participants. Domestic brands including YILI, Ausnutria, and Scient have emerged as major players with registered premium formulas that compete directly with international brands at comparable price points and with strong local retail and e-commerce distribution advantages. International brands maintain premium trust associations but face intensifying competition from increasingly sophisticated domestic manufacturers.

Japan

Japan's Baby Milk Powder market is mature, technically sophisticated, and characterized by the country's exceptionally high parenting standards and strong preference for domestic product quality and safety assurance. Japanese formula products are known for their meticulous formulation standards and the incorporation of bioactive ingredients including lactoferrin, nucleotides, and specific probiotic strains with documented clinical backing. Japanese consumer trust in domestic brands is strong, giving domestic players including Meiji and Morinaga significant competitive advantage over international entrants.

Japan's declining birth rate is a structural headwind for market volume growth, moderating the total addressable market over time. However, this demographic challenge is partially offset by continued premiumization and the expansion of specialty and functional formula segments as parental investment per child intensifies. The Japanese market also has a well-developed clinical formula channel serving medically indicated needs including allergy management and metabolic disorder nutrition.

Southeast Asia

Southeast Asia represents one of the most commercially dynamic and heterogeneous regional Baby Milk Powder markets globally. The region's combination of large and growing infant populations, rapid urbanization and lifestyle modernization, rising maternal workforce participation, and a growing middle class with increasing discretionary spending on infant nutrition creates powerful structural demand growth conditions across Indonesia, Vietnam, Thailand, Malaysia, Philippines, and Singapore.

The region is characterized by significant market segmentation by country — Singapore and Malaysia host some of the region's most sophisticated and premium-oriented consumers, while Indonesia and Vietnam offer mass-market volume opportunities at more accessible price points. Both international premium brands and cost-competitive Asian alternatives serve this diverse market. E-commerce and modern trade retail are growing rapidly across the region, improving access to international formula brands in markets where traditional retail infrastructure is less developed.

India

India's Baby Milk Powder market is at a pivotal growth inflection, driven by the country's large and growing infant population, increasing urbanization reducing breastfeeding duration and exclusivity, rising female labor force participation, a rapidly expanding middle class, and growing pediatric healthcare infrastructure that is increasing awareness of and access to infant nutrition products. India has one of the world's highest absolute birth rates, making it one of the most significant long-term volume growth opportunities in the global market.

The Indian market is currently concentrated in urban and semi-urban areas, with rural penetration significantly lower due to income constraints and traditional breastfeeding practices. However, rising incomes, improving healthcare access, and increasing maternal awareness of formula options are progressively expanding the addressable market. International brands including Nestle, Abbott, and Mead Johnson maintain strong market positions, while domestic players including Nestle India's locally manufactured products compete effectively across the mass and mid-market segments.

Competitive Landscape

Market Structure & Tier Overview

The global Baby Milk Powder market is among the most brand-concentrated in the consumer health and nutrition industries, reflecting the exceptional importance of trust, safety assurance, and scientific credibility in a category where product quality directly affects vulnerable infant health. The competitive landscape is structured around a small group of global nutrition companies whose formula brands command extraordinary parental trust across multiple geographies, a set of regionally powerful domestic players in key Asian markets, and a secondary tier of premium specialty and organic formula brands serving distinct consumer segments.

The concentration of the market at the top tier is reinforced by the significant regulatory compliance costs of market entry — formula registration, compositional compliance, clinical documentation for specialty products — and the marketing restrictions that limit the ability of new entrants to build brand awareness through conventional advertising channels. These structural barriers sustain the competitive positions of established players while limiting the pace at which new competitors can challenge for market share.

Key Market Participants

Strategic Competitive Trends

•       Human Milk Oligosaccharide (HMO) Innovation: The commercial introduction of multiple HMO structures — beginning with 2'-FL and now extending to multi-HMO blends including LNnT, 3-FL, and others — has become the most differentiating product innovation platform in the global formula market. Leading manufacturers are racing to develop and clinically validate multi-HMO formulas and use HMO content as a premium positioning platform, particularly in Stage 1 infant formula targeted at the Under 6 Months age group.

•       Gut Microbiome Science Integration: Advances in understanding the infant gut microbiome and its critical role in immune development, metabolic programming, and cognitive function are translating into formula innovations incorporating specific probiotic strains (L. reuteri, B. infantis, B. longum), prebiotic mixtures, and postbiotic ingredients. Brands that can integrate credible microbiome science into their formula platforms are establishing meaningful differentiation in both standard and specialty formula segments.

•       Premiumization and Origin Authenticity: In Asian markets — particularly China — the perceived origin of formula ingredients (New Zealand dairy, European organic, Dutch or German farm standards) is a powerful purchase driver. Brands that can credibly communicate ingredient sourcing authenticity, farm-to-tin traceability, and premium geographical origin are capturing disproportionate share of the highest-value consumer segment.

•       Direct-to-Consumer Digital Commerce: The formula market globally is experiencing a significant channel shift toward brand-owned digital storefronts, subscription programs, and parenting community platforms that allow brands to own the consumer relationship directly, provide personalized nutrition guidance, and build loyalty ecosystems that extend across the full formula stage progression.

•       Specialty Formula Expansion: Multiple manufacturers are investing in expanding their allergy, intolerance, and functional formula portfolios, recognizing that this segment commands price premiums 2–5x above standard formula and benefits from strong healthcare professional recommendation channels that are insulated from marketing restrictions applying to standard formula advertising.

•       Sustainability and Ethical Sourcing: Growing parental sensitivity to environmental and ethical considerations is driving investment in organic certification, sustainable dairy sourcing, carbon footprint reduction, and recyclable packaging across the formula market — particularly in European and North American markets where these values are most commercially salient.

Market Drivers, Restraints & Opportunities

Key Growth Drivers

•       Rising Birth Rates and Population Growth in Developing Markets: High birth rates across South and Southeast Asia, the Middle East, Africa, and Latin America are expanding the global infant formula consumer base, with hundreds of millions of new potential formula users entering the market annually as urbanization and lifestyle modernization reduce exclusive breastfeeding rates.

•       Increasing Maternal Workforce Participation: The growing proportion of women in formal employment globally — particularly in rapidly urbanizing Asian and African economies — is a structural driver of formula adoption, as workforce participation reduces the ability to maintain exclusive breastfeeding beyond the early weeks of infancy.

•       Premiumization of Infant Nutrition: Parental willingness to invest in premium and ultra-premium formula products — incorporating HMOs, probiotics, organic ingredients, and scientifically advanced formulations — is driving significant value growth above and beyond unit volume growth in mature and developing markets alike.

•       Rising Rates of Infant Allergy and Special Dietary Needs: Increasing diagnosis of cow's milk protein allergy, lactose intolerance, reflux, and other infant feeding challenges is expanding the addressable market for special formula products that command substantial price premiums over standard formula.

•       Expanding Neonatal Care Infrastructure: Improvements in neonatal intensive care capabilities — particularly in middle-income countries — are increasing premature infant survival rates and expanding the clinical patient base for specialized premature infant formula.

•       Health-Conscious Parenting Trends: Growing cultural emphasis on early-life nutrition as foundational to long-term health, cognitive development, and disease risk — amplified by social media parenting communities and pediatric health advocacy — is intensifying parental investment in nutritionally optimized formula products.

Market Restraints & Challenges

•       Breastfeeding Promotion and WHO Code Compliance: Government and public health promotion of breastfeeding as the optimal infant feeding practice — supported by restrictive marketing regulations under the WHO Code — creates a cultural and regulatory environment that moderates formula adoption and limits marketing communications, particularly for Stage 1 products targeting the Under 6 Months age group.

•       Declining Birth Rates in Developed Economies: Structural declines in birth rates across Japan, South Korea, Germany, Italy, and other developed markets are reducing the underlying population base for infant formula consumption in some of the world's highest-value markets, creating a structural headwind for volume growth.

•       Regulatory Complexity and Market Entry Barriers: The rigorous and evolving regulatory requirements for formula composition, registration, and marketing across multiple jurisdictions impose significant compliance costs and create barriers to product launches, particularly for new market entrants and smaller manufacturers.

•       Consumer Trust Sensitivity and Safety Incidents: The baby nutrition market is uniquely sensitive to safety incidents — contamination events, recall episodes, or quality concerns can cause rapid and severe brand trust damage that takes years and significant investment to repair, as demonstrated by the lasting impact of China's 2008 melamine scandal.

Market Opportunities

•       Organic and Clean Label Formula Growth: Consumer demand for organic-certified, minimally processed, and clean-label infant formula — with transparent ingredient sourcing and no artificial additives — is a high-growth premium segment that remains underpenetrated in most markets outside Western Europe and represents a significant commercial opportunity for brands with credible organic supply chains.

•       Personalized Infant Nutrition: Advances in microbiome science, genetic nutrition research, and digital health platforms are creating the early foundations for personalized formula — products formulated or recommended based on individual infant characteristics, microbiome profiles, or maternal health data. While still early-stage, this represents a transformative long-term opportunity.

•       Sub-Saharan Africa and Emerging Market Expansion: The enormous and growing infant population of Sub-Saharan Africa, combined with rapidly rising urbanization and income levels, represents one of the longest-duration market expansion opportunities in the global infant nutrition industry — particularly for brands able to offer cost-accessible, nutritionally appropriate formula products adapted to local dietary contexts.

•       Clinical Nutrition for Premature and Low-Birth-Weight Infants: Improvements in neonatal care globally are expanding the addressable clinical market for premature infant formula in middle-income countries, and the development of next-generation highly specialized neonatal nutrition products with advanced bioactive profiles represents a high-value innovation frontier.

•       Digital Parenting Ecosystem Development: The development of comprehensive digital parenting platforms — combining formula subscription, personalized feeding guidance, pediatric nutrition advice, and community engagement — creates opportunities to build deep, loyalty-generating consumer relationships that extend across the full formula stage progression and generate significant lifetime customer value.